Michael Zhang

Principal Consultant/Solution Architect, Enterprise Networks and Security at Compugen - Holon, Tel Aviv, IL

Michael Zhang's Colleagues at Compugen
Lynda Creighton

Senior Project Coordinator

Contact Lynda Creighton

Sonia Crosse

Distribution project administrator

Contact Sonia Crosse

Doug Adams

Deal Registration Specialist - Retired

Contact Doug Adams

Eduard Hofstede

Advanced Solutions Sales Specialist, C&C

Contact Eduard Hofstede

View All Michael Zhang's Colleagues
Michael Zhang's Contact Details
HQ
+972 3-765-8585
Location
Company
Compugen
Michael Zhang's Company Details
Compugen logo, Compugen contact details

Compugen

Holon, Tel Aviv, IL • 80 Employees
BioTech/Drugs

Compugen is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify new drug targets and biological pathways for developing cancer immunotherapies. Compugen has developed two proprietary product candidates: COM701, a potential first-in-class anti-PVRIG antibody and COM902, a potential best-in-class monoclonal antibody targeting TIGIT for the treatment of solid tumors. Partnered programs include bapotulimab, an antibody targeting ILDR2, in Phase 1 development, licensed to Bayer under a research and discovery collaboration and license agreement, and a TIGIT/PD-1 bispecific derived from COM902 (AZD2936) in Phase 1/2 development by AstraZeneca through a license agreement for the development of bispecific and multi-specific antibodies. In addition, the Company’s therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets. The most advanced program, COM503 is about to enter pre-IND enabling studies. COM503 is a potential first-in-class, high affinity antibody targeting cytokine biology to enhance anti-tumor immunity in a differentiated manner. Compugen is headquartered in Israel, with offices in South San Francisco, CA. Compugen’s shares are listed on Nasdaq and the Tel Aviv Stock Exchange under the ticker symbol CGEN. For more information, please visit http://www.cgen.com/. #Immunooncology #Oncology #Immunology #Biotechnology #TIGIT #PVRIG #DNAM1 #ComputationalBiology #DrugDevelopment #Innovation

Compugen Compucanltd Compugem Israel Gene Ontoloyg Large Scale Compugen Revenue
Details about Compugen
Frequently Asked Questions about Michael Zhang
Michael Zhang currently works for Compugen.
Michael Zhang's role at Compugen is Principal Consultant/Solution Architect, Enterprise Networks and Security.
Michael Zhang's email address is ***@cgen.com. To view Michael Zhang's full email address, please signup to ConnectPlex.
Michael Zhang works in the BioTech/Drugs industry.
Michael Zhang's colleagues at Compugen are Johnson Xu, Lynda Creighton, Sonia Crosse, Brady Steele, Doug Adams, Eduard Hofstede, Glennie George and others.
Michael Zhang's phone number is +972 3-765-8585
See more information about Michael Zhang